
Janux Therapeutics, Inc.
USD15.70
+0.38 (+2.45%)
CEO
David Alan Campbell
IPO Date
2021-06-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.37
Prev. Close
$15.32
Day Low
$15.27
Day High
$15.76
52W Low
$12.12
52W High
$35.34
Market Cap
$0.96B
Volume
0.16M
| 28 Apr 2026 |
| Jones Trading |
| Buy |
| Buy |
| maintain |
| 20 Apr 2026 | Barclays | Overweight | Underweight | downgrade |
| 15 Apr 2026 | UBS | Buy | Neutral | downgrade |
| 27 Feb 2026 | Guggenheim | Buy | Buy | maintain |
| 27 Feb 2026 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 20 Jan 2026 | Clear Street | Buy | Hold | downgrade |
| 16 Jan 2026 | Piper Sandler | Overweight | Overweight | maintain |